- Alibaba : HSBC adjusts price target to $270 from $288, maintains buy rating
- AstraZeneca: Goldman Sachs keeps Sell rating. The target price differs slightly and is now set at GBp 6950 versus GBp 6800
- Barclays: Goldman Sachs keeps Buy rating. The target price remains unchanged at GBp 260.
- Capital & Counties: Berenberg initiates a buy rating on the stock, targeting GBp 200.
- Citigroup : Seaport Global adjusts price target to $61 from $57, maintains buy rating
- Domtar : TD Securities downgrades to tender rating from hold, adjusts price target to $55.50 from $56
- Ford Motor : Zacks Investment Research upgrades to outperform from neutral, adjusts pt to $17 from $16
- GlaxoSmithKline: Goldman Sachs maintains his Buy rating on the stock. The target price is reviewed upwards from GBp 1800 to GBp 1870.
- Goldman Sachs : Seaport Global adjusts price target to $430 from $411, maintains buy rating
- HSBC: Credit Suisse retains its Neutral opinion on the stock. The target price is unchanged at GBp 465.
- IAG: Credit Suisse keeps Buy rating. The target price has been revised upwards and is now set at GBp 256, compared with GBp 228 previously.
- IG Group: Jefferies resumes its Buy rating with a target of GBp 1050.
- Morgan Stanley : Seaport Global adjusts price target to $97 from $87, maintains buy rating
- Monday com : Oppenheimer initiates coverage on monday.com with outperform rating, $260 price target
- Shaftesbury: Berenberg starts tracking as Buy, targeting GBp 725.
- State Street : Seaport Global adjusts price target to $103 from $97, maintains buy rating
- Vodafone: Goldman Sachs advises its customers to buy the stock. The target price is still set at GBp 180.
- Wells Fargo & Company : Seaport Global adjusts price target to $55 from $51, maintains buy rating
- 3M Company: Credit Suisse downgrades to neutral from outperform, adjusts price target to $212 from $210